Acuta Capital Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-131,454
| Closed | -$5.17M | – | 51 |
|
|
2023
Q2 | $5.17M | Sell |
131,454
-149,046
| -53% | -$5.86M | 3.5% | 10 |
|
|
2023
Q1 | $6.82M | Sell |
280,500
-80,000
| -22% | -$1.95M | 5.03% | 8 |
|
|
2022
Q4 | $7.72M | Sell |
360,500
-203,107
| -36% | -$4.35M | 4.75% | 8 |
|
|
2022
Q3 | $10.1M | Hold |
563,607
| – | – | 4.35% | 5 |
|
|
2022
Q2 | $5.42M | Buy |
563,607
+24,107
| +4% | +$232K | 3.02% | 12 |
|
|
2022
Q1 | $9.08M | Buy |
539,500
+69,500
| +15% | +$1.17M | 4.24% | 6 |
|
|
2021
Q4 | $7.86M | Sell |
470,000
-665,000
| -59% | -$11.1M | 3.3% | 8 |
|
|
2021
Q3 | $18.4M | Sell |
1,135,000
-115,000
| -9% | -$1.87M | 6.5% | 3 |
|
|
2021
Q2 | $7.89M | Sell |
1,250,000
-329,093
| -21% | -$2.08M | 3.15% | 7 |
|
|
2021
Q1 | $9.76M | Buy |
1,579,093
+366,593
| +30% | +$2.27M | 3.52% | 5 |
|
|
2020
Q4 | $8.38M | Buy |
1,212,500
+410,000
| +51% | +$2.83M | 2.28% | 18 |
|
|
2020
Q3 | $4.53M | Buy |
802,500
+115,000
| +17% | +$649K | 1.23% | 25 |
|
|
2020
Q2 | $3.51M | Buy |
687,500
+548,500
| +395% | +$2.8M | 1.01% | 34 |
|
|
2020
Q1 | $478K | Sell |
139,000
-771,000
| -85% | -$2.65M | 0.23% | 31 |
|
|
2019
Q4 | $7.81M | Buy |
+910,000
| New | +$7.81M | 1.93% | 16 |
|